Try the modernized beta website. Learn more about the modernization effort.

Key Record Dates Identifier: NCT03515837
Brief Title: Study of Pemetrexed + Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With Tyrosine Kinase Inhibitor- (TKI)-Resistant Epidermal Growth Factor Receptor- (EGFR)-Mutated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-789/KEYNOTE-789)

First Submitted : April 23, 2018
First Submitted that Met QC Criteria : April 23, 2018
First Posted : May 4, 2018

Last Update Submitted that Met QC Criteria : February 9, 2021
Last Update Posted : February 12, 2021